The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩10,667.05Fair value₩16,002.76Bull₩70,046.93
FairClose
52-week traded range
52W low ₩7,470.0052W high ₩10,710.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
INFINITT Healthcare Co., Ltd. closed at ₩8,700.00, 45.6% below the consensus fair value of ₩16,002.76 drawn from 10 valuation models.
Financial DNA score 84/100 — Exceptional. P/E of 8.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩10,667.05
+22.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩13,821.14
+58.9%
√(22.5 × EPS × BVPS)
EPS=1083.2, BVPS=7837.84
Graham Formula
₩70,046.93
+705.1%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩21,664.00
+149.0%
EPS × 20x (sector P/E)
EPS=1083.2, Sector P/E=20x
Peter Lynch (PEG)
₩26,278.43
+202.1%
EPS × Growth% (PEG = 1 is fair)
EPS=1083.2, g=24.3%
EV/EBITDA
₩11,949.37
+37.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=16.43B
Dividend Discount (DDM)
₩14,563.80
+67.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=269.7, r=10%, g=8%
Book Value (P/B)
₩15,225.00
+75.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=7837.84, ROE=13.8%, g=6%, r=10%
Reverse DCF
₩8,700.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -5.4% | Historical: 24.3%
Margin of Safety
₩21,787.34
+150.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=29049.78, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.